Report by the Scientific and Technical Committee for Central Blood Authority on the implications for the National Blood Transfusion Service of an adverse report on the Blood Products Laboratory at Elstree by the Inspectors of Medicines Division. Discusses the fact that NHS relies heavily on them for plasma fractions and explains that the plant is not up to modern standards and there is a lack of finances.